云天励飞拟港股IPO，公司回应

Core Viewpoint - The company, Yuntian Lifei, has submitted an application for an H-share IPO on the Hong Kong Stock Exchange, aiming to establish a dual financing platform for internationalization and to meet strategic development and funding needs [2][3]. Group 1: Financial Performance - Yuntian Lifei's revenue for the years 2022, 2023, 2024, and the first quarter of 2025 were 546 million, 506 million, 917 million, and 264 million respectively [4]. - Research and development expenditures for the same periods were 347 million, 295 million, 400 million, and 83.9 million, representing 63.4%, 58.3%, 43.6%, and 31.8% of total revenue respectively [5]. Group 2: Customer and Supplier Dynamics - Revenue from the top five customers accounted for 49%, 47.5%, 57.3%, and 84.2% of total revenue for the years 2022, 2023, 2024, and the first quarter of 2025 respectively [5]. - The largest customer contributed 28.9%, 17.4%, 20.5%, and 47% of total revenue during the same periods [5]. - The company’s top five suppliers accounted for 30.2%, 34.3%, 31.4%, and 41.2% of total procurement in the years 2022, 2023, 2024, and the first quarter of 2025 respectively [5]. Group 3: IPO Fund Utilization - The funds raised from the IPO will primarily be used for the research and development of AI inference chips and related products, seeking strategic investment and acquisition opportunities, enhancing sales and marketing capabilities, and general corporate purposes [5].